# Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota

> **NCT02040922** · — · UNKNOWN · sponsor: **University of Nottingham** · enrollment: 450 (estimated)

## Conditions studied

- Campylobacter Infections
- Irritable Bowel Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02040922
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2017-02
- **Final completion:** 2017-06
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2017-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02040922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02040922, "Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02040922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*